» Articles » PMID: 32503591

Non-coding RNAs Shuttled Via Exosomes Reshape the Hypoxic Tumor Microenvironment

Overview
Journal J Hematol Oncol
Publisher Biomed Central
Specialties Hematology
Oncology
Date 2020 Jun 7
PMID 32503591
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are small extracellular vesicles secreted by almost all the cells. Molecular cargos of exosomes can partially reflect the characteristics of originating cells. Exosome-mediated cell-to-cell interactions in the microenvironment are critical in cancer progression. Hypoxia, a key pro-cancerous feature of the tumor microenvironment, alters the releasing and contents of exosomes. A growing body of evidence shows that hypoxia induces more aggressive phenotypes in cancer. Of note, non-coding RNAs shuttled in hypoxic tumor-derived exosomes have been demonstrated as fundamental molecules in regulating cancer biology and remodeling tumor microenvironment. Furthermore, these hypoxic tumor-derived exosomal non-coding RNAs can be detected in the body fluids, serving as promising diagnostic and prognostic biomarkers. The current review discusses changes in cancer behaviors regulated by exosomes-secreted non-coding RNAs under hypoxic conditions.

Citing Articles

Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research.

Sharma R, Yadav J, Bhat S, Musayev A, Myrzagulova S, Sharma D Mol Neurobiol. 2025; .

PMID: 39804528 DOI: 10.1007/s12035-024-04680-w.


Hypoxia-related bioinformatic signatures associated with prognosis and tumor microenvironment of pancreatic cancer: Current status, concerns, and future perspectives.

Li D, Cao X, Jiang J World J Gastroenterol. 2024; 30(44):4689-4696.

PMID: 39610772 PMC: 11580612. DOI: 10.3748/wjg.v30.i44.4689.


Prostate cancer cell-derived exosomes ZNF667-AS1 reduces TGFBR1 mRNA stability to inhibit Treg expansion and DTX resistance by binding to U2AF1.

Shi Z, Pu W, Li M, Aihemaitijiang M, Li S, Zhang X Mol Med. 2024; 30(1):179.

PMID: 39425009 PMC: 11488200. DOI: 10.1186/s10020-024-00947-z.


Hypoxic tumor-derived exosomal miR-4488 induces macrophage M2 polarization to promote liver metastasis of pancreatic neuroendocrine neoplasm through RTN3/FABP5 mediated fatty acid oxidation.

Lu F, Ye M, Shen Y, Xu Y, Hu C, Chen J Int J Biol Sci. 2024; 20(8):3201-3218.

PMID: 38904015 PMC: 11186367. DOI: 10.7150/ijbs.96831.


The interplay between the tumor microenvironment and tumor-derived small extracellular vesicles in cancer development and therapeutic response.

Guo X, Song J, Liu M, Ou X, Guo Y Cancer Biol Ther. 2024; 25(1):2356831.

PMID: 38767879 PMC: 11110713. DOI: 10.1080/15384047.2024.2356831.


References
1.
Kuchuk O, Tuccitto A, Citterio D, Huber V, Camisaschi C, Milione M . pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma. Oncoimmunology. 2018; 7(7):e1445452. PMC: 5993489. DOI: 10.1080/2162402X.2018.1445452. View

2.
Umezu T, Tadokoro H, Azuma K, Yoshizawa S, Ohyashiki K, Ohyashiki J . Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014; 124(25):3748-57. PMC: 4263983. DOI: 10.1182/blood-2014-05-576116. View

3.
Bavelloni A, Ramazzotti G, Poli A, Piazzi M, Focaccia E, Blalock W . MiRNA-210: A Current Overview. Anticancer Res. 2017; 37(12):6511-6521. DOI: 10.21873/anticanres.12107. View

4.
Wahlestedt C . Targeting long non-coding RNA to therapeutically upregulate gene expression. Nat Rev Drug Discov. 2013; 12(6):433-46. DOI: 10.1038/nrd4018. View

5.
El Andaloussi S, Mager I, Breakefield X, Wood M . Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013; 12(5):347-57. DOI: 10.1038/nrd3978. View